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Suchresearchhashighpriority for showing
programmes ways to use scarce resources
effectively for the long term control of
trachoma in their communities.
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In June and July of this year, an opera-tional study to test the feasibility of
usingcommunityhealthvolunteers (CHVs)
to distribute azithromycin was undertaken
in the Daboya subdistrict of GhanaÕs
Northern Region. The objectives of the
study were as follows:
l To test the ability and accuracy of com-
munity health volunteers (CHVs) in
diagnosing active trachoma.
l To test the ability of CHVs to give the
correct dose of azithromycin by weight
to children and adults.
l To test the ability of CHVs to keep
records of tablets received and distrib-
uted.
l To test the ability of CHVs to warn
patients about possible adverse reac-
tions, recognise them when they occur
and take appropriate action if required.
l To test the feasibility of using azithro-
mycin tablets in pre-school children.
l To document the response of each
household to all occupants being offered
azithromycin.
l To examine the relationship between
height and weight in individuals requir-
ing azithromycin for trachoma control.
The six volunteers, who have previously
been involved in the Guinea Worm and
Onchocerciasis Control Programmes as
well as the distribution of ocular tetracyc-
line for trachoma control, were given four
days of revision on trachoma, and training
in the use of azithromycin. Education ses-
sions included theory, practical sessions
teaching eye examination skills and the
techniques for weighing and measuring,
dose calculation and drug preparation. The
CHVs then examined a total of 675 indi-
viduals in ninety households in local vil-
lages, looking for evidence of trachoma.
They were accompanied by supervisors
who independently examined all subjects,
and intervened in treatment only when mis-
takes were about to be made. Azithromycin
(a single dose of approximately 20mg/kg)
was given to all individuals in any house-
hold in which there was at least one case of
active trachoma.
The volunteers performed creditably.
The decision to treat or not treat each
household was correct on more than four
out of every five occasions. The dosing
reliability and drug management skills of
CHVs were generally good. Community
response was very positive, refusal of
examination or treatment rare, and adverse
reactions infrequent.
Both 250mg tablets and suspension
200mg/5mL were available. Nearly all
those 4 years of age and older were able to
take tablets. Height and weight data was
recorded for all individuals in treatable
households, and the correlation between
the two suggests that height could be used
instead of weight for dose determination
for those people able to take tablets. Given
the practical difficulties involved with
using weighing scales in remote settings,
this finding could be of great potential
benefit. Unfortunately, using height or
length to predict dose for children requir-
ing suspension was less reliable. 
The major problems encountered in the
study were weighing procedures, the use of
azithromycin suspension, and volunteersÕ
record keeping. 
At the conclusion of the study, both vol-
unteers and supervisors felt that a longer
training period would have been of benefit.
It is suggested that future education efforts
would place more emphasis on the diagno-
sisofTFandTIattheexpenseoftimespent
learning about TS and CO. Additionally,
more teaching time should be devoted to
drug side-effects and record keeping skills. 
A paper is in preparation.
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